Salt Lake City-based Recursion, a digital biology company, has secured $239 million in Series D financing. Leaps by Bayer, the impact investment arm of Bayer AG, led the round.
Source: Press Release
Digital biology firm Recursion racks up $239m Series D
Salt Lake City-based Recursion, a digital biology company, has secured $239 million in Series D financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: